PUBLISHER: The Business Research Company | PRODUCT CODE: 1926177
PUBLISHER: The Business Research Company | PRODUCT CODE: 1926177
High-performance liquid chromatography (HPLC) is a technique employed to separate, identify, and quantify the components within a mixture. It plays a crucial role in the quantitative determination of plasma levels of drugs and their metabolites, particularly in the development of novel medications and therapy monitoring.
The primary products associated with high-performance liquid chromatography include instruments, consumables, accessories, and software. HPLC instrumentation typically comprises nine basic components, incorporating data collection, an output system, and connective tubing and fittings. These components find application in various fields such as clinical research, diagnostics, forensics, and others. The technology is utilized by diverse end-users, including pharmaceutical and biotechnology companies, academic and research institutes, food and beverage companies, hospitals and clinics, environmental agencies, and other entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are affecting the high-performance liquid chromatography market by increasing costs of imported precision instruments, detectors, pumps, electronic components, and specialty consumables such as columns and solvents. Pharmaceutical and biotechnology hubs in North America and Europe are most affected due to reliance on imported analytical equipment, while Asia-Pacific faces higher costs for export-oriented instrument manufacturing. These tariffs are raising laboratory capital expenditure and extending procurement cycles. However, they are also encouraging regional manufacturing, local assembly of HPLC systems, and development of cost-optimized analytical solutions.
The high-performance liquid chromatography market research report is one of a series of new reports from The Business Research Company that provides high-performance liquid chromatography market statistics, including high-performance liquid chromatography industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The high-performance liquid chromatography market size has grown rapidly in recent years. It will grow from $6.73 billion in 2025 to $7.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to expansion of pharmaceutical research activities, growth in clinical diagnostics testing, increasing regulatory emphasis on drug safety, rising adoption of chromatography in food testing, availability of advanced analytical instruments.
The high-performance liquid chromatography market size is expected to see rapid growth in the next few years. It will grow to $11.62 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising demand for high-throughput analytical platforms, expansion of biopharmaceutical pipelines, growing use of digital chromatography data systems, increasing focus on real-time analytical monitoring. Major trends in the forecast period include increasing adoption of uhplc systems, rising demand for high-sensitivity analytical techniques, growing integration of automated sample handling, expansion of hplc use in drug development, enhanced focus on data accuracy and compliance.
The increasing number of ongoing clinical trials is expected to drive the growth of the high-performance liquid chromatography (HPLC) market in the coming years. Clinical trials are research studies involving human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic methods. HPLC plays a critical role in these trials by providing precise analysis of pharmaceutical compounds and biomarkers, ensuring drug safety and efficacy. It supports quality control, pharmacokinetic studies, and biomarker quantification to facilitate drug development and patient safety. For example, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the growing number of clinical trials is propelling the growth of the HPLC market.
Key companies in the market are developing advanced high-performance liquid chromatography (HPLC) technologies, such as integrated HPLC, for various research applications. For example, in April 2024, Waters Corporation, a U.S.-based life sciences firm, introduced the Alliance iS Bio. This system is specifically designed for biopharmaceutical applications, ensuring precise and reliable separation of complex biological molecules. It features smart technology that aids quality control analysts, thereby reducing operational errors and enhancing system performance. The system addresses up to 40% of common errors, which minimizes the time spent investigating failed runs and out-of-spec results. By improving workflow efficiency, it allows for faster and more accurate results in biopharma quality control processes.
In July 2024, Catalyze Partners, a U.S.-based firm focused on transforming innovative technologies, acquired Axcend, LLC, for an undisclosed sum. This acquisition enhances Catalyze Partners' capacity to address the growing demand for advanced analytical solutions in sectors such as pharmaceuticals, environmental monitoring, and chemical manufacturing. Axcend, LLC, is a U.S.-based company specializing in high-performance liquid chromatography systems.
Major companies operating in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Merck Millipore, Hitachi Ltd., Phenomenex Inc., JASCO Corporation, Gilson Inc., Knauer GmbH, SIELC Technologies, Tosoh Bioscience LLC, YMC Co. Ltd., GL Sciences Inc., Sepax Technologies Inc., Restek Corporation, Hamilton Company, ACE HPLC Columns, Advanced Chromatography Technologies Ltd., Analytical Sales and Services Inc., Chromatography Research Supplies Inc., Daicel Corporation, Eksigent Technologies LLC, Hichrom Limited
North America was the largest region in the high-performance liquid chromatography market analysis in 2025. Asia-Pacific is expected to be the fastest-growing region in the global high performance liquid chromatography market during the forecast period. The regions covered in the high-performance liquid chromatography market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the high-performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The high-performance liquid chromatography market includes revenues earned by entities by providing reverse phase columns, normal phase columns, ion exchange columns, and size exclusion columns. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High-Performance Liquid Chromatography Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses high-performance liquid chromatography market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for high-performance liquid chromatography ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high-performance liquid chromatography market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.